Back
Catalyst Pharmaceuticals Vs. BioVie Industry Stock Comparison
Sell
46
CPRX
Catalyst Pharmaceuticals
Last Price:
21.12
Seasonality Move:
4.48%
Sell
36
BIVI
BioVie
Last Price:
3.19
Seasonality Move:
13.44%
Sell
46
Catalyst Pharmaceuticals (CPRX)
is a Sell
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $21.15. The Score for CPRX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
BioVie (BIVI)
is a Sell
Is BioVie a Buy, Sell or Hold?
- The current BioVie [BIVI] share price is $3.36. The Score for BIVI is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- BIVI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $21.15
The current trend is moderately bearish and CPRX is experiencing selling pressure, which indicates risk of future bearish movement.
BIVI Stock Price Chart
CPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 45.52 | Sell |
| Chaikin Money Flow: | -620645 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.05 - 22.71) | Sell |
| Bollinger Bands (100): | (17.44 - 21.66) | Buy |
BIVI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 62.4 | Buy |
| Chaikin Money Flow: | -1138222 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.34 - 3.32) | Buy |
| Bollinger Bands (100): | (1.89 - 3.87) | Buy |
CPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.87 | Sell |
| 20-day SMA: | 22.02 | Sell |
| 50-day SMA: | 21.05 | Buy |
| 200-day SMA: | 17.49 | Buy |
| 8-day EMA: | 21.61 | Sell |
| 20-day EMA: | 21.75 | Sell |
| 50-day EMA: | 21.05 | Buy |
| 200-day EMA: | 18.19 | Buy |
BIVI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.3 | Buy |
| 20-day SMA: | 2.93 | Buy |
| 50-day SMA: | 2.32 | Buy |
| 200-day SMA: | 4.68 | Sell |
| 8-day EMA: | 3.25 | Buy |
| 20-day EMA: | 2.92 | Buy |
| 50-day EMA: | 2.68 | Buy |
| 200-day EMA: | 7.71 | Sell |
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.05 per share.
BioVie Earnings Growth & BIVI Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.80 per share, and an increase next year of $7.39 per share.
Catalyst Pharmaceuticals Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioVie Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||